{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:17:16Z","timestamp":1785766636776,"version":"3.56.0"},"reference-count":39,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T00:00:00Z","timestamp":1637366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000199","name":"United States Department of Agriculture","doi-asserted-by":"publisher","award":["2018-68003-27463"],"award-info":[{"award-number":["2018-68003-27463"]}],"id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Veterinary Sciences"],"abstract":"<jats:p>Bovine anaplasmosis, caused by the intracellular rickettsial pathogen Anaplasma marginale, is the most prevalent tick-transmitted disease of cattle worldwide. In the U.S., tetracycline antimicrobials are commonly used to treat and control anaplasmosis. Oxytetracycline, administered by injection, is indicated for treatment of clinical anaplasmosis in beef and dairy cattle and calves. Chlortetracycline, administered orally, is indicated for control of active anaplasmosis infection in beef and nonlactating dairy cattle. Tetracyclines have been demonstrated to be effective for treating active anaplasmosis, but their ability to eliminate A. marginale at currently approved therapeutic doses or dosing regimens remains unclear. In the absence of approved dosing regimens for A. marginale clearance, a study was conducted to determine the effect of approved oxytetracycline and chlortetracycline indications on A. marginale bacteremia. Fifteen animals with persistent anaplasmosis were enrolled and divided into three treatment groups. Group 1 (n = 6) received oral chlortetracycline (1.1 mg\/kg bodyweight) administered via hand-fed medicated feed for 60 consecutive days. Group 2 (n = 6) received injectable oxytetracycline administered subcutaneously at 19.8 mg\/kg bodyweight three times in 3-week intervals. Group 3 (n = 3) served as an untreated control. After 60 days, bacteremia failed to permanently decrease in response to treatment. This result indicates that clearance of A. marginale is unlikely to be reliably achieved using currently approved tetracycline-based regimens to manage anaplasmosis.<\/jats:p>","DOI":"10.3390\/vetsci8110283","type":"journal-article","created":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T21:02:06Z","timestamp":1637528526000},"page":"283","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Failure to Eliminate Persistent Anaplasma marginale Infection from Cattle Using Labeled Doses of Chlortetracycline and Oxytetracycline Antimicrobials"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3087-2841","authenticated-orcid":false,"given":"Andrew K.","family":"Curtis","sequence":"first","affiliation":[{"name":"Department of Anatomy and Physiology, Kansas State University College of Veterinary Medicine, Manhattan, KS 66506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9453-3657","authenticated-orcid":false,"given":"Michael D.","family":"Kleinhenz","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Kansas State University College of Veterinary Medicine, Manhattan, KS 66506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tippawan","family":"Anantatat","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Medicine\/Pathobiology, Kansas State University College of Veterinary Medicine, Manhattan, KS 66506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4746-5011","authenticated-orcid":false,"given":"Miriam S.","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Physiology, Kansas State University College of Veterinary Medicine, Manhattan, KS 66506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine C.","family":"Magnin","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Physiology, Kansas State University College of Veterinary Medicine, Manhattan, KS 66506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1802-3991","authenticated-orcid":false,"given":"Johann F.","family":"Coetzee","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Physiology, Kansas State University College of Veterinary Medicine, Manhattan, KS 66506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6569-7580","authenticated-orcid":false,"given":"Kathryn E.","family":"Reif","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Medicine\/Pathobiology, Kansas State University College of Veterinary Medicine, Manhattan, KS 66506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0304-4017(94)03107-8","article-title":"International collaborative research: Significance of tick-borne hemoparasitic diseases to world animal health","volume":"57","author":"Uilenberg","year":"1995","journal-title":"Vet. Parasitol."},{"key":"ref_2","unstructured":"Kreir, J. (1977). Bovine anaplasmosis. Parasitic Protozoa, Academic Press Inc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0169-4758(99)01469-6","article-title":"Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale","volume":"15","author":"Palmer","year":"1999","journal-title":"Parasitol. Today"},{"key":"ref_4","first-page":"2045","article-title":"A textbook of the diseases of cattle, horses, sheep, pigs and goats","volume":"10","author":"Radostits","year":"2007","journal-title":"Vet. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1128\/jcm.31.8.2091-2096.1993","article-title":"Impact of persistent Anaplasma marginale rickettsemia on tick infection and transmission","volume":"31","author":"Eriks","year":"1993","journal-title":"J. Clin. Microbiol."},{"key":"ref_6","unstructured":"Alderink, F.J., and Dietrich, R.A. (1983). Economic and epidemiological implications of anaplasmosis in Texas beef cattle herds. Bulletin\/Texas Agricultural Experiment Station, Texas Agricultural Experiment Station (USA). No. 1426."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1128\/CMR.16.4.698-712.2003","article-title":"Antigens and alternatives for control of Anaplasma marginale infection in cattle","volume":"16","author":"Kocan","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_8","first-page":"100258","article-title":"Seroprevalence of bovine anaplasmosis in Georgia","volume":"15","author":"Okafor","year":"2019","journal-title":"Vet. Parasitol. Reg. Stud. Rep."},{"key":"ref_9","first-page":"100301","article-title":"Factors associated with seroprevalence of bovine anaplasmosis in Mississippi, USA","volume":"17","author":"Okafor","year":"2019","journal-title":"Vet. Parasitol. Reg. Stud. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1128\/iai.58.4.1117-1119.1990","article-title":"Cyclic rickettsemia during persistent Anaplasma marginale infection of cattle","volume":"58","author":"Kieser","year":"1990","journal-title":"Infect. Immun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.vetpar.2009.09.012","article-title":"The natural history of Anaplasma marginale","volume":"167","author":"Kocan","year":"2010","journal-title":"Vet. Parasitol."},{"key":"ref_12","first-page":"63","article-title":"Bovine anaplasmosis: Elimination of the carrier state with injectable long-acting oxytetracycline","volume":"183","author":"Swift","year":"1983","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_13","unstructured":"(2021, September 01). USDA ARS, Available online: https:\/\/www.ars.usda.gov\/ARSUserFiles\/np103\/Action%20Plan%20-%20Animal%20Health%202022-2027_final.pdf."},{"key":"ref_14","unstructured":"The Merck Veterinary Manual. Merck & Co., Inc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","article-title":"Understanding the mechanisms and drivers of antimicrobial resistance","volume":"387","author":"Holmes","year":"2016","journal-title":"Lancet"},{"key":"ref_16","unstructured":"(2021, September 01). FDA Center for Veterinary Medicine 2016 Summary Report, Available online: https:\/\/www.fda.gov\/media\/109457\/download."},{"key":"ref_17","unstructured":"(2021, September 15). FDA Code of Federal Regulations Title 21, Volume 6, Part 522, Sec 1660a, Available online: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=522.1660a."},{"key":"ref_18","unstructured":"(2021, September 15). FDA Code of Federal Regulations Title 21, Volume 6, Part 558, Sec 128, Available online: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=558.128&SearchTerm=chlortetracycline."},{"key":"ref_19","first-page":"1115","article-title":"Elimination of the carrier state of bovine anaplasmosis with a long-acting oxytetracycline","volume":"39","author":"Roby","year":"1978","journal-title":"Am. J. Vet. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.vetpar.2004.08.017","article-title":"Comparison of three oxytetracycline regimens for the treatment of persistent Anaplasma marginale infections in beef cattle","volume":"127","author":"Coetzee","year":"2005","journal-title":"Vet. Parasitol."},{"key":"ref_21","first-page":"83","article-title":"The comparative efficiency of a short and a long acting oxytetracycline for the treatment of Anaplasma marginale in splenectomized calves","volume":"50","author":"Stewart","year":"1979","journal-title":"J. S. Afr. Vet. Assoc."},{"key":"ref_22","first-page":"347","article-title":"Relative efficacy of two oxytetracycline formulations and doxycycline in the treatment of acute anaplasmosis in splenectomized calves","volume":"39","author":"Kuttler","year":"1978","journal-title":"Am. J. Vet. Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Catanese, H.N., Brayton, K.A., and Gebremedhin, A.H. (2016). RepeatAnalyzer: A tool for analyzing and managing short-sequence repeat data. BMC Genom., 17.","DOI":"10.1186\/s12864-016-2686-2"},{"key":"ref_24","first-page":"347","article-title":"Comparison of the efficacy of enrofloxacin, imidocarb, and oxytetracycline for clearance of persistent Anaplasma marginale infections in cattle","volume":"7","author":"Coetzee","year":"2006","journal-title":"Vet. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.vetmic.2010.02.031","article-title":"The efficacy of three chlortetracycline regimens in the treatment of persistent Anaplasma marginale infection","volume":"145","author":"Reinbold","year":"2010","journal-title":"Vet. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/CVI.00246-14","article-title":"Immunization-induced Anaplasma marginale-specific T-lymphocyte responses impaired by A. marginale infection are restored after eliminating infection with tetracycline","volume":"21","author":"Turse","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"skz392","DOI":"10.1093\/jas\/skz392","article-title":"Development of a subcutaneous ear implant to deliver an anaplasmosis vaccine to dairy steers","volume":"98","author":"Curtis","year":"2020","journal-title":"J. Anim. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1016\/j.vaccine.2013.04.069","article-title":"Protective immunity induced by immunization with a live, cultured Anaplasma marginale strain","volume":"31","author":"Hammac","year":"2013","journal-title":"Vaccine"},{"key":"ref_29","unstructured":"(2021, September 12). Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug evaluation and Research (CDER), Center for Veterinary Medicine (CVM), May 2018, Available online: https:\/\/www.fda.gov\/media\/70858\/download."},{"key":"ref_30","unstructured":"Kuttler, K., Johnson, L., and Simpson, J. (1980, January 2\u20137). Chemotherapy to eliminate Anaplasma marginale under field and laboratory conditions. Proceedings of the United States Animal Health Association, Louisville, KY, USA."},{"key":"ref_31","first-page":"2170","article-title":"Elimination of naturally acquired chronic Anaplasma marginale infections with a long-acting oxytetracycline injectable","volume":"43","author":"Magonigle","year":"1982","journal-title":"Am. J. Vet. Res."},{"key":"ref_32","first-page":"1","article-title":"Efficacy of Long acting oxytetracycline on bovine anaplasmosis","volume":"35","year":"1988","journal-title":"Ank. \u00dcniversitesi Vet. Fak\u00fcltesi Derg."},{"key":"ref_33","first-page":"2223","article-title":"Serologic and clinical responses of preimmunized, vaccinated, and previously infected cattle to challenge exposure by two different Anaplasma marginale isolates","volume":"45","author":"Kuttler","year":"1984","journal-title":"Am. J. Vet. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0378-1135(90)90185-X","article-title":"Comparison of a DNA probe, complement-fixation and indirect immunofluorescence tests for diagnosing Anaplasma marginale in suspected carrier cattle","volume":"24","author":"Goff","year":"1990","journal-title":"Vet. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/BF03546832","article-title":"A comparison of two oxytetracycline formulations in cattle","volume":"23","author":"Luthman","year":"1982","journal-title":"Acta Vet. Scand."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/BF03546763","article-title":"Oxytetracyclines in Cattle","volume":"24","author":"Xia","year":"1983","journal-title":"Acta Vet. Scand."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2885.2009.1116.x","article-title":"Plasma pharmacokinetics of oral chlortetracycline in group fed, ruminating, Holstein steers in a feedlot setting","volume":"33","author":"Reinbold","year":"2010","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"ref_38","unstructured":"US Climate Data (2020, September 15). Manhattan, Kansas. Available online: https:\/\/www.usclimatedata.com\/climate\/bartow\/florida\/united-states\/usfl0027\/2014\/9."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.21423\/bovine-vol54no1p51-57","article-title":"Clinical effectiveness of enrofloxacin 100 mg\/mL injectable solution for the treatment of acute anaplasmosis in cattle caused by Anaplasma marginale","volume":"54","author":"Shane","year":"2020","journal-title":"Bov. Pract."}],"container-title":["Veterinary Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-7381\/8\/11\/283\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:33:15Z","timestamp":1760167995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-7381\/8\/11\/283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,20]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["vetsci8110283"],"URL":"https:\/\/doi.org\/10.3390\/vetsci8110283","relation":{},"ISSN":["2306-7381"],"issn-type":[{"value":"2306-7381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,20]]}}}